Onderneming Marinus Pharmaceuticals, Inc. London S.E.
Aandelen
0JYL
US56854Q2003
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
13,97 USD | -0,43% |
|
+795,46% | +25,84% |
17/05 | Sectorupdate: Gezondheidszorgaandelen eind van de middag gemengd | MT |
17/05 | Sectorupdate: Gezondheidszorg | MT |
Vakgebied
Aantal werknemers: 166
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutics for Rare Seizures
100,0
%
| 25 | 100,0 % | 31 | 100,0 % | +21,63% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 25 | 100,0 % | 31 | 100,0 % | +21,63% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05-09-18 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 12-04-21 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 06-11-19 |
Chief Tech/Sci/R&D Officer | - | - | |
Sonya Weigle
IRO | Public Communications Contact | - | 01-09-21 |
Christy Shafer
PRN | Corporate Officer/Principal | 48 | 10-11-20 |
General Counsel | - | - | |
Thomas Lyons
PRN | Corporate Officer/Principal | - | 01-01-18 |
Alex Aimetti
PRN | Corporate Officer/Principal | - | - |
Martha Manning
LAW | General Counsel | 69 | 15-06-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 01-12-08 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05-09-18 |
Elan Ezickson
BRD | Director/Board Member | 60 | 12-12-19 |
Seth Fischer
BRD | Director/Board Member | 68 | 06-09-16 |
Sara Nochur
BRD | Director/Board Member | 63 | 22-03-21 |
Sarah Noonberg
BRD | Director/Board Member | 56 | 16-05-23 |
Director/Board Member | 41 | 26-01-23 | |
Charles Austin
BRD | Director/Board Member | 68 | 29-07-20 |
Marvin Johnson
BRD | Director/Board Member | 61 | 18-04-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 54 941 081 | 54 403 089 ( 99,02 %) | 7 307 ( 0,0133 %) | 99,02 % |
Bedrijfsgegevens
Marinus Pharmaceuticals, Inc.
5 Radnor Corporate Center 100 Matsonford Road
19087-5279, Radnor
+484 801 4670
http://www.marinuspharma.com![Adres Marinus Pharmaceuticals, Inc.(0JYL)](https://cdn.zonebourse.com/static/address/40331425.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+50,70% | 791 mld. | |
+41,96% | 630 mld. | |
-7,15% | 350 mld. | |
+18,77% | 328 mld. | |
+8,79% | 298 mld. | |
+18,02% | 246 mld. | |
+1,27% | 225 mld. | |
+11,95% | 218 mld. | |
+3,68% | 160 mld. |
- Beurs
- Aandelen
- Koers MRNS
- Koers 0JYL
- Onderneming Marinus Pharmaceuticals, Inc.